Last reviewed · How we verify

NCT04827758: STRAS

Evaluation of a Screening Strategy for Sarcopenia: a Monocentric Prospective Cohort Study (STRAS)

Terminated NA Last updated 28 October 2022
What this trial tests

NA trial testing Screening and diagnostic tests for sarcopenia in Sarcopenia in 15 participants. Terminated before completion.

Timeline
22 April 2021
Primary endpoint
23 September 2022
23 September 2022

Quick facts

Lead sponsorGroupe Hospitalier de la Region de Mulhouse et Sud Alsace
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment15
Start date22 April 2021
Primary completion23 September 2022
Estimated completion23 September 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

Who can join

60 and older, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to determine the prevalence of sarcopenia in patients hospitalized in the follow-up care and rehabilitation units of the geriatrics department of the Mulhouse French hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Groupe Hospitalier de la Region de Mulhouse et Sud Alsace trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04827758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing